Skip To Content

Dr. Bernard Prigent

Vice President & Medical Director, Pfizer Canada Inc.

Doctor Prigent is Vice-President and Medical Director of Pfizer Canada, the Canadian operation of Pfizer Inc., the world's leading research based pharmaceutical company.

Under his leadership, Pfizer Canada has become one of the top R&D investors within the Canadian Life Science Sector. These investments cover most aspects of pharmaceutical R&D from discovery to clinical trials as well as alliances with the biotech sector and partnerships with academic institutions, federal and provincial funding agencies.

His current activities within the Life Science Sector include:

  • Board Member of the Canadian Arthritis Network
  • Chair of the Scientific Committee of the Research Foundation of Rx&D
  • Member of the Strategic Advisory Committee of two C.E.C.R. initiatives: Center of Excellence in Personalized Medicine and Prevention (CEPM) and Prevention of Epidemic Organ Failure (PROOF)
  • Chairman of the Strategic Orientation Committee of Quebec Consortium for Drug Discovery (CQDM)
  • Board Member of the Alberta Institute of Health Economics

Dr. Prigent joined Pfizer in 1995 and occupied positions of increasing responsibility before becoming Vice-President and Medical director in January 2001.